Northern Trust Corp Boosts Holdings in U.S. Physical Therapy, Inc. $USPH

Northern Trust Corp boosted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 4.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 274,117 shares of the company's stock after acquiring an additional 12,292 shares during the period. Northern Trust Corp owned about 1.80% of U.S. Physical Therapy worth $19,835,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in USPH. Dimensional Fund Advisors LP boosted its holdings in shares of U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock valued at $37,818,000 after buying an additional 7,890 shares in the last quarter. Aquatic Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after buying an additional 198 shares in the last quarter. Tudor Investment Corp ET AL boosted its holdings in shares of U.S. Physical Therapy by 9.7% in the 4th quarter. Tudor Investment Corp ET AL now owns 16,792 shares of the company's stock valued at $1,490,000 after buying an additional 1,490 shares in the last quarter. Baird Financial Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 16.7% in the 4th quarter. Baird Financial Group Inc. now owns 6,156 shares of the company's stock valued at $546,000 after buying an additional 882 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its holdings in shares of U.S. Physical Therapy by 22.9% in the 4th quarter. Balyasny Asset Management L.P. now owns 9,453 shares of the company's stock valued at $839,000 after buying an additional 1,759 shares in the last quarter.

U.S. Physical Therapy Stock Performance

USPH stock traded down $0.70 during trading on Friday, reaching $85.12. The company had a trading volume of 78,030 shares, compared to its average volume of 142,636. The firm has a 50-day simple moving average of $79.67 and a 200-day simple moving average of $76.73. The company has a market cap of $1.29 billion, a price-to-earnings ratio of 37.17, a price-to-earnings-growth ratio of 4.20 and a beta of 1.47. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.19.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company had revenue of $197.34 million during the quarter, compared to analysts' expectations of $190.24 million. During the same period last year, the business earned $0.73 EPS. U.S. Physical Therapy's revenue for the quarter was up 18.0% on a year-over-year basis. As a group, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy's payout ratio is presently 78.60%.

Wall Street Analyst Weigh In

USPH has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Barrington Research raised their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a report on Friday, August 8th. Finally, Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.25.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 763 shares of the company's stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $84.97, for a total value of $64,832.11. Following the completion of the sale, the chief operating officer owned 21,483 shares of the company's stock, valued at approximately $1,825,410.51. This represents a 3.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Nancy Ham sold 400 shares of the company's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director directly owned 2,594 shares of the company's stock, valued at $202,357.94. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 3,653 shares of company stock valued at $311,274. 2.00% of the stock is owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.